2026 EARLY CONFIRMED SPEAKERS

 

MARCH 30 - APRIL 02, 2026
WALTER E. WASHINGTON CONVENTION CENTER, WASHINGTON D.C.

 

 
 

Brian Abramson, Board of Directors, National Vaccine Law Association

Haritha Adhikarla, Senior Translational Immunology Lead, CEPI

Haritha Adhikarla | Senior Translational Immunology Lead | CEPI » speaking at Vaccine Congress USA

Galit Alter, Associate Professor Of Medicine, Harvard Medical School

Galit Alter | Associate Professor Of Medicine | Harvard Medical School » speaking at Vaccine Congress USA

Pascal Barollier, Chief Engagement and Information Officer, Gavi, the vaccine Alliance

Pascal Barollier | Chief Engagement and Information Officer | Gavi, the vaccine Alliance » speaking at Vaccine Congress USA

Navneet Bichha, Senior Program Officer, The INCLEN Trust International

David Burkhart, CEO, Inimmune Corp

David Burkhart | CEO | Inimmune Corp » speaking at Vaccine Congress USA

Robert Chen, Scientific Director, BRIGHTON Collaboration

Robert Chen | Scientific Director | BRIGHTON Collaboration » speaking at Vaccine Congress USA

Dennis Christensen, Head of Global R&D, Croda

Dennis Christensen | Head of Global R&D | Croda » speaking at Vaccine Congress USA

Kashmira Date, Senior Director, Medical & Scientific Affairs (Pipeline Vaccines), pfizer

Kashmira Date | Senior Director, Medical & Scientific Affairs (Pipeline Vaccines) | pfizer » speaking at Vaccine Congress USA

Stephen Framil, Corporate Global Head of Accessibility, Merck & Co. Inc.

Stephen Framil | Corporate Global Head of Accessibility | Merck & Co. Inc. » speaking at Vaccine Congress USA

Cyril Gay, Science Advisor, Countermeasures Discovery, Development, and Strategic Public-Private Partnerships, USDA

Cyril Gay | Science Advisor, Countermeasures Discovery, Development, and Strategic Public-Private Partnerships | USDA » speaking at Vaccine Congress USA

Andrew Geall, Chief Development Officer, Replicate Bioscience, Inc.

Andrew Geall | Chief Development Officer | Replicate Bioscience, Inc. » speaking at Vaccine Congress USA

Bruce Gellin, Professor of Medicine, Georgetown University School Of Medicine

Bruce Gellin | Professor of Medicine | Georgetown University School Of Medicine » speaking at Vaccine Congress USA

Christian Harding, CSO & Co-founder, Omniose

Christian Harding | CSO & Co-founder | Omniose » speaking at Vaccine Congress USA

Bill Hausdorff, Lead, Meningococcal Vaccine Development and Vaccines Public Health Value Proposition and, PATH, Center for Vaccine Innovation and Access

Bill Hausdorff | Lead, Meningococcal Vaccine Development and Vaccines Public Health Value Proposition and | PATH, Center for Vaccine Innovation and Access » speaking at Vaccine Congress USA

Peter Hotez, Professor, Baylor College of Medicine

Peter Hotez | Professor | Baylor College of Medicine » speaking at Vaccine Congress USA

David Humphreys, Executive Advisor, Triangulate health Ltd

David Humphreys | Executive Advisor | Triangulate health Ltd » speaking at Vaccine Congress USA

Maria Karasarides, Former Vice President, Worldwide Medical Oncology, Early Assets & Biomarkers, The Delphina Group

Maria Karasarides | Former Vice President, Worldwide Medical Oncology, Early Assets & Biomarkers | The Delphina Group » speaking at Vaccine Congress USA

Jerome Kim, Director General, ivi

Jerome Kim | Director General | ivi » speaking at Vaccine Congress USA

Holger Kissel, Senior Vice President, Biontech

Charles Kline, Associate Vice President, Merck

Charles Kline | Associate Vice President | Merck » speaking at Vaccine Congress USA

Mahesh Kumar, Senior VP, Global Biologics R&D, Zoetis

Mahesh Kumar | Senior VP, Global Biologics R&D | Zoetis » speaking at Vaccine Congress USA

Arvind Kumar, Vice President of Research, BiomEdit

Arvind Kumar | Vice President of Research | BiomEdit » speaking at Vaccine Congress USA

Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital

Ofer Levy | Director, Precision Vaccines Program | Boston Children's Hospital » speaking at Vaccine Congress USA

Francesca Micoli, Director GVGH Innovation Academy and Senior Project Leader, GVGH

Francesca Micoli | Director GVGH Innovation Academy and Senior Project Leader | GVGH » speaking at Vaccine Congress USA

Sania Nishtar, Chief Executive Officer, Gavi, the vaccine Alliance

Sania Nishtar | Chief Executive Officer | Gavi, the vaccine Alliance » speaking at Vaccine Congress USA

Mayur Patel, VP Global R&D Product Development and Portfolio Management, Elanco

Mayur Patel | VP Global R&D Product Development and Portfolio Management | Elanco » speaking at Vaccine Congress USA

Sandeep Patel, CEO, Humanity Health Ventures

Sandeep Patel | CEO | Humanity Health Ventures » speaking at Vaccine Congress USA

Gregory Poland, Director of Mayo Vaccine Research Group, Mayo Clinic

Gregory Poland | Director of Mayo Vaccine Research Group | Mayo Clinic » speaking at Vaccine Congress USA

Angela Shen, Consultant, University of Pennsylvania

Angela Shen | Consultant | University of Pennsylvania » speaking at Vaccine Congress USA

Lora Shimp, Director - Immunization Center, John Snow Inc

Lora Shimp | Director - Immunization Center | John Snow Inc » speaking at Vaccine Congress USA

Walter Straus, Vice President, Clinical Safety & Risk Management, Moderna Therapeutics

Walter Straus | Vice President, Clinical Safety & Risk Management | Moderna Therapeutics » speaking at Vaccine Congress USA

Vic Suarez, Principal Growth Partner, Blu Zone Bioscience

Vic Suarez | Principal Growth Partner | Blu Zone Bioscience » speaking at Vaccine Congress USA

Valeria Szijarto, Director of Bacterial Vaccine Discovery, Astrazeneca

Valeria Szijarto | Director of Bacterial Vaccine Discovery | Astrazeneca » speaking at Vaccine Congress USA

Prashant Yadav, Senior Fellow, Council on Foreign Relations

Prashant Yadav | Senior Fellow | Council on Foreign Relations » speaking at Vaccine Congress USA